Guerbet S.A. Stock
Your prediction
Pros and Cons of Guerbet S.A. in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Guerbet S.A. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Guerbet S.A. | 0.310% | -1.517% | 3.180% | 93.385% | 68.309% | -2.259% | -42.054% |
Boiron S.A. | -0.600% | -1.039% | 3.571% | -16.521% | -15.995% | -14.487% | -34.736% |
Virbac S.A. | 1.090% | 3.938% | 11.128% | 29.877% | 2.925% | 46.047% | 142.136% |
Onxeo S.A. | -7.680% | -9.833% | 12.708% | -65.868% | -28.581% | -85.359% | -87.073% |
News
Guerbet: Change in Guerbet’s Board of Directors.
Guerbet: Change in Guerbet’s Board of Directors.
Guerbet: 2023 full-year results.
Guerbet: 2023 full-year results.
Guerbet strengthens its Executive Committee with two new appointments to consolidate its medium and long-term ambitions.
Guerbet strengthens its Executive Committee with two new appointments to consolidate its medium and long-term ambitions.